Triple

T22796974
Position Surface form Disambiguated ID Type / Status
Subject AveXis E564274 entity
Predicate formerName P65 FINISHED
Object Biolife Cell Bank NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Biolife Cell Bank | Statement: [AveXis, formerName, Biolife Cell Bank]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Biolife Cell Bank
Context triple: [AveXis, formerName, Biolife Cell Bank]
  • A. Alcor Life Extension Foundation
    Alcor Life Extension Foundation is a nonprofit organization that specializes in cryonics, preserving humans and animals at low temperatures after legal death in the hope of future revival.
  • B. NordGen
    NordGen is the Nordic Genetic Resource Center, an intergovernmental organization that safeguards and manages plant, animal, and forest genetic resources for the Nordic countries.
  • C. Lazarus Laboratories
    Lazarus Laboratories is a fictional research and development organization, often depicted as a cutting-edge but morally ambiguous scientific facility in speculative and superhero-related media.
  • D. Innogen
    Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
  • E. Centre for Biobanking
    The Centre for Biobanking is a specialized unit within Norway’s public health system that manages the collection, storage, and use of biological samples for research and public health purposes.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Biolife Cell Bank
Target entity description: Biolife Cell Bank was the original name of AveXis, a biotechnology company focused on developing gene therapies for rare neurological diseases.
  • A. Alcor Life Extension Foundation
    Alcor Life Extension Foundation is a nonprofit organization that specializes in cryonics, preserving humans and animals at low temperatures after legal death in the hope of future revival.
  • B. NordGen
    NordGen is the Nordic Genetic Resource Center, an intergovernmental organization that safeguards and manages plant, animal, and forest genetic resources for the Nordic countries.
  • C. Lazarus Laboratories
    Lazarus Laboratories is a fictional research and development organization, often depicted as a cutting-edge but morally ambiguous scientific facility in speculative and superhero-related media.
  • D. Innogen
    Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
  • E. Centre for Biobanking
    The Centre for Biobanking is a specialized unit within Norway’s public health system that manages the collection, storage, and use of biological samples for research and public health purposes.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2458185f88190b0045227ee420411 completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17cd9b3c0819096050f43a829ec0d completed April 29, 2026, 3:36 a.m.
Created at: April 17, 2026, 3:30 p.m.